Taiwan Advanced Nanotech Inc. (6797) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Taiwan Advanced Nanotech Inc. (6797:TWSE), powered by AI.

Current Price
$13.70
Sector
Healthcare
What is the Taiwan Advanced Nanotech Inc. stock price forecast?

Taiwan Advanced Nanotech Inc. is currently trading at $13.70. View real-time AI analysis on Alpha Lenz.

What is Taiwan Advanced Nanotech Inc. insider trading activity?

View the latest insider trading data for Taiwan Advanced Nanotech Inc. on Alpha Lenz.

What is Taiwan Advanced Nanotech Inc.'s P/E ratio?

View Taiwan Advanced Nanotech Inc.'s valuation metrics on Alpha Lenz.

Taiwan Advanced Nanotech Inc.

TWSE · 6797
NT$13.70+0.60(+4.58%)
Ask about Taiwan Advanced Nanotech Inc.'s future dividend policy...
Alpha Chat Insight

Taiwan Advanced Nanotech Inc.'s ROE is -25.5%. Explore profitability and growth together.

Ask for details

Company Overview

Taiwan Advanced Nanotech Inc. is a healthcare equipment manufacturer specializing in advanced molecular diagnostics technologies. The company focuses on the design and production of automated nucleic acid extraction instruments, nanomagnetic beads, and purification reagents, offering total solutions for DNA and RNA extraction from diverse biological samples such as blood, tissue, plants, and microorganisms. Its product portfolio includes automated extraction machines, specialized reagent kits, and consumables like spin tips and deep well plates, all of which are supported by international certifications such as GMP, ISO 13485, FDA, and CE approvals. Established in 2004 and headquartered in Taoyuan, Taiwan, Taiwan Advanced Nanotech Inc. serves both domestic and global markets and holds patents across Europe, North America, and several Asian countries. The company's technologies are essential to diagnostic laboratories, hospitals, and research institutions, underpinning a wide range of applications from medical diagnostics to disease monitoring. By providing OEM/ODM services, Taiwan Advanced Nanotech Inc. further supports innovation and customization within the biotechnology sector. Its leadership in nucleic acid extraction and automated diagnostics positions the company as a key enabler for advancing molecular medicine and public health.

CEOMr. Chien Hsing Chien
SectorHealthcare
IndustryMedical Devices
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$154.37MRevenue
0.00Shares Out
0Employees

Margins

-49.10%Gross
-75.89%EBITDA
-150.51%Operating
-146.79%Pre-Tax
-146.79%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-51.18%Rev 3Yr
-38.25%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-17.27%ROA
-25.46%ROE
-16.81%ROIC

Financial Health

NT$193.25MCash & Cash Equivalents
NT$283.26MNet Debt
61.69%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Taiwan Advanced Nanotech Inc. (ticker: 6797) is a company listed on TWSE in the Healthcare sector (Medical Devices).

The current price is 13.7 with a P/E ratio of -x and P/B of -x.

ROE is -25.46% and operating margin is -150.51%. Annual revenue is $154M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Taiwan Advanced Nanotech Inc. (6797) Stock Forecast 2026 $13.70 — Price, Financials & Analyst Targets | Alpha Lenz